161 related articles for article (PubMed ID: 2966608)
1. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
[TBL] [Abstract][Full Text] [Related]
2. Trospectomycin, a novel spectinomycin analogue: antibacterial activity and preliminary human pharmacokinetics.
Zurenko GE; Ford CW; Novak E
Drugs Exp Clin Res; 1988; 14(6):403-9. PubMed ID: 2975212
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.
Barry AL; Jones RN; Thornsberry C
Antimicrob Agents Chemother; 1989 Apr; 33(4):569-72. PubMed ID: 2524997
[TBL] [Abstract][Full Text] [Related]
4. The bactericidal activity and postantibiotic effect of trospectomycin.
Yagi BH; Schaadt RD; Zurenko GE
Diagn Microbiol Infect Dis; 1992 Jul; 15(5):417-23. PubMed ID: 1386566
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
Montiel F; Kaltwasser G; Pinto ME; Lam M
Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.
Rolston K; Ho DH; Bodey GP
Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):254-60. PubMed ID: 2523806
[TBL] [Abstract][Full Text] [Related]
7. The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococci.
Khardori N; Gandhi M; Adame J; Kalvakuntla L; Rosenbaum B; Bodey GP
J Antimicrob Chemother; 1990 May; 25(5):777-85. PubMed ID: 2142683
[TBL] [Abstract][Full Text] [Related]
8. Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.
Jacobus NV; Tally FP
Antimicrob Agents Chemother; 1988 Apr; 32(4):584-6. PubMed ID: 2967671
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
Gismondo MR; Chisari G; Lo Bue AM
Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
Johnson CC; Wendeler M; Levison ME
Antimicrob Agents Chemother; 1990 Aug; 34(8):1597-9. PubMed ID: 2145801
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a new antibacterial drug, trospectomycin sulphate (U-63,366F), against Bacteroides strains isolated from the vagina.
Testore GP; Terranova L; Salanitro A; Sordillo P; Foli A; Giacomello F; Andreoni M
Chemotherapy; 1993; 39(2):124-7. PubMed ID: 8458245
[TBL] [Abstract][Full Text] [Related]
12. The in vitro activity of trospectomycin against anaerobic bacteria.
Chisari G; Lo Bue AM; Nicoletti G
J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
[TBL] [Abstract][Full Text] [Related]
13. Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.
Bruhn DF; Waidyarachchi SL; Madhura DB; Shcherbakov D; Zheng Z; Liu J; Abdelrahman YM; Singh AP; Duscha S; Rathi C; Lee RB; Belland RJ; Meibohm B; Rosch JW; Böttger EC; Lee RE
Sci Transl Med; 2015 May; 7(288):288ra75. PubMed ID: 25995221
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
Yancey RJ; Klein LK
J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
[TBL] [Abstract][Full Text] [Related]
15. Effects of trospectomycin on serum sensitivity of Escherichia coli UC 9451.
Cialdella JI; Ulrich RG; Liggett WF; Adams LD; Marshall VP
Antimicrob Agents Chemother; 1990 Nov; 34(11):2086-92. PubMed ID: 2149919
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
LiPuma JJ; Daley B; Stull TL
J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A).
Westblom TU; Midkiff BR; Czinn SJ
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):560-2. PubMed ID: 8404921
[TBL] [Abstract][Full Text] [Related]
18. Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.
Veringa EM; Ferguson DA; Lambe DW; Verhoef J
Zentralbl Bakteriol; 1989 Sep; 271(3):311-20. PubMed ID: 2529862
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium.
Mobarakai N; Landman D; Quale JM
J Antimicrob Chemother; 1994 Feb; 33(2):319-21. PubMed ID: 8182013
[No Abstract] [Full Text] [Related]
20. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
Vogt K; Rodloff AC; Hahn H
Infection; 1991; 19(3):138-9. PubMed ID: 1832417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
